<p>Avacta Group Plc (LON:AVCT - 獲取免費報告) 的股價在週三交易中下跌了 14.6%。該公司的股價最低曾達到 66.40 便士，最後交易價為 67.50 便士。在午間交易中，約有 4,507,580 股成交，較日均成交量 2,250,242 股增加了 100%。該股票此前收盤價為 79 便士。</p>
<h2>華爾街分析師觀點</h2>
<p>另外，Peel Hunt 在 10 月 13 日的研究報告中重申了對 Avacta Group 的 “買入” 評級，並設定了 99 便士的目標價。根據 MarketBeat 的數據，一位股票研究分析師對該股票給予了買入評級，目前該公司的共識評級為 “買入”，平均目標價為 99 便士。</p>
<p><strong>查看我們關於 AVCT 的最新研究報告</strong></p>
<h2>Avacta Group 價格表現</h2>
<p>該公司的市值為 3.0487 億英鎊，市盈率為-4.01，貝塔值為 1.12。公司的債務與股本比率為 52.53，速動比率為 4.96，流動比率為 1.29。該股票的 50 日移動平均價格為 73.83 便士，200 日移動平均價格為 54.95 便士。</p>
<p>Avacta Group (LON:AVCT - 獲取免費報告) 最近於 9 月 30 日發佈了季度財報。這家生物技術公司報告該季度每股收益為-4.46 便士。Avacta Group 的股本回報率為-74.00%，淨利潤率為-114.45%。股票分析師預測 Avacta Group Plc 在本年度的每股收益將為-9.9011833 便士。</p>
<h2>Avacta Group 公司簡介</h2>
<p>(獲取免費報告)</p>
<p>Avacta Therapeutics 是一家臨牀階段的生物製藥公司，挑戰當前的藥物遞送方法，以擴大高效癌症治療藥物的應用。該公司受益於世界一流的研發設施、團隊中極具才華的科學家以及經驗豐富的管理團隊，成員分佈在倫敦總部和美國。我們的專有 pre|CISION®平台通過將毒性藥物結合到一種僅能被腫瘤特異性蛋白酶（成纖維細胞活化蛋白 FAP）切割的短肽上，從而掩蓋毒性藥物。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票，優於 Avacta Group</li>
<li>如何投資科技股及值得考慮的頂級科技股</li>
<li>為什麼台灣半導體的 6.5% 下跌可能是一個明智的買入機會</li>
<li>值得考慮的 5 只高評級分紅股票</li>
<li>RTX 因國防訂單激增而飆升至歷史新高</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>聰明的錢正在購買汽車供應商，而不是汽車品牌</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Avacta Group 嗎？</h2>
<p>在考慮 Avacta Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 Avacta Group 並不在名單上。</p>
<p>雖然 Avacta Group 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Avacta Group Plc（倫敦證券交易所代碼：AVCT）的股價在週三下跌了 14.6%，至 67.50 便士，交易量是平均水平的兩倍。儘管股價下跌，Peel Hunt 仍維持 “買入” 評級，目標價為 99 便士。該公司報告了本季度每股收益為負的 4.46 便士，並面臨重大財務挑戰。Avacta 專注於生物製藥，利用其專有的 pre|CISION®平台專注於癌症治療</p>

<p>Avacta Group Plc (LON:AVCT - Get Free Report)'s share price dropped 14.6% during trading on Wednesday . The company traded as low as GBX 66.40 and last traded at GBX 67.50. Approximately 4,507,580 shares changed hands during mid-day trading, an increase of 100% from the average daily volume of 2,250,242 shares. The stock had previously closed at GBX 79.</p>
<div class="lb-trans"><p>Avacta Group Plc (LON:AVCT - 獲取免費報告) 的股價在週三交易中下跌了 14.6%。該公司的股價最低曾達到 66.40 便士，最後交易價為 67.50 便士。在午間交易中，約有 4,507,580 股成交，較日均成交量 2,250,242 股增加了 100%。該股票此前收盤價為 79 便士。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>Separately, Peel Hunt restated a &#34;buy&#34; rating and set a GBX 99 price objective on shares of Avacta Group in a research report on Monday, October 13th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of &#34;Buy&#34; and an average price target of GBX 99.</p>
<div class="lb-trans"><p>另外，Peel Hunt 在 10 月 13 日的研究報告中重申了對 Avacta Group 的 “買入” 評級，並設定了 99 便士的目標價。根據 MarketBeat 的數據，一位股票研究分析師對該股票給予了買入評級，目前該公司的共識評級為 “買入”，平均目標價為 99 便士。</p>
</div><p><strong>View Our Latest Research Report on AVCT</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 AVCT 的最新研究報告</strong></p>
</div><h2>Avacta Group Price Performance</h2>
<div class="lb-trans"><h2>Avacta Group 價格表現</h2>
</div><p>The company has a market capitalization of £304.87 million, a PE ratio of -4.01 and a beta of 1.12. The company has a debt-to-equity ratio of 52.53, a quick ratio of 4.96 and a current ratio of 1.29. The stock has a 50 day moving average price of GBX 73.83 and a two-hundred day moving average price of GBX 54.95.</p>
<div class="lb-trans"><p>該公司的市值為 3.0487 億英鎊，市盈率為-4.01，貝塔值為 1.12。公司的債務與股本比率為 52.53，速動比率為 4.96，流動比率為 1.29。該股票的 50 日移動平均價格為 73.83 便士，200 日移動平均價格為 54.95 便士。</p>
</div><p>Avacta Group (LON:AVCT - Get Free Report) last released its quarterly earnings data on Tuesday, September 30th. The biotechnology company reported GBX (4.46) EPS for the quarter. Avacta Group had a negative return on equity of 74.00% and a negative net margin of 114.45%. Equities analysts forecast that Avacta Group Plc will post -9.9011833 earnings per share for the current year.</p>
<div class="lb-trans"><p>Avacta Group (LON:AVCT - 獲取免費報告) 最近於 9 月 30 日發佈了季度財報。這家生物技術公司報告該季度每股收益為-4.46 便士。Avacta Group 的股本回報率為-74.00%，淨利潤率為-114.45%。股票分析師預測 Avacta Group Plc 在本年度的每股收益將為-9.9011833 便士。</p>
</div><h2>Avacta Group Company Profile</h2>
<div class="lb-trans"><h2>Avacta Group 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics. The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US. Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).</p>
<div class="lb-trans"><p>Avacta Therapeutics 是一家臨牀階段的生物製藥公司，挑戰當前的藥物遞送方法，以擴大高效癌症治療藥物的應用。該公司受益於世界一流的研發設施、團隊中極具才華的科學家以及經驗豐富的管理團隊，成員分佈在倫敦總部和美國。我們的專有 pre|CISION®平台通過將毒性藥物結合到一種僅能被腫瘤特異性蛋白酶（成纖維細胞活化蛋白 FAP）切割的短肽上，從而掩蓋毒性藥物。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Avacta Group</li>
<li>How to Invest in Tech Stocks and Top Tech Stocks to Consider</li>
<li>Why Taiwan Semiconductor's 6.5% Dip Could Be a Smart Buy</li>
<li>5 Top Rated Dividend Stocks to Consider</li>
<li>RTX Surges to Record Highs as Defense Orders Explode</li>
<li>How to Effectively Use the MarketBeat Ratings Screener</li>
<li>Smart Money Is Buying Auto Suppliers, Not Car Brands</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，優於 Avacta Group</li>
<li>如何投資科技股及值得考慮的頂級科技股</li>
<li>為什麼台灣半導體的 6.5% 下跌可能是一個明智的買入機會</li>
<li>值得考慮的 5 只高評級分紅股票</li>
<li>RTX 因國防訂單激增而飆升至歷史新高</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>聰明的錢正在購買汽車供應商，而不是汽車品牌</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Avacta Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Avacta Group 嗎？</h2>
</div><p>Before you consider Avacta Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Avacta Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avacta Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 Avacta Group 並不在名單上。</p>
</div><p>While Avacta Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Avacta Group 目前在分析師中獲得了買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Avacta Group (LON:AVCT) 的股價下跌了 14.6% - 以下是原因